Persistent Infection with Ebola Virus under Conditions of Partial Immunity

Journal of Virology

Volumn 78, Issue 2, 2004, Pages 958-967

  Gupta, Manisha ^a,d   Mahanty, Siddhartha ^a,e   Greer, Patricia ^b   Towner, Jonathan S ^a   Shieh, Wun Ju ^b   Zaki, Sherif R ^b   Ahmed, Rafi ^c   Rollin, Pierre E ^a,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; VIRUS ANTIGEN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DEATH; EBOLA VIRUS; IMMUNE DEFICIENCY; IMMUNITY; INFECTION PREVENTION; MEMORY CELL; MORTALITY; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS HEMORRHAGIC FEVER;

ACUTE DISEASE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MICE; VERO CELLS; VIRUS REPLICATION;

EID: 0346688631     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.2.958-967.2004     Document Type: Article

References (42)

1. Accorsi, S., M. Fabiani, M. Lukwiya, P. A. Onek, P. D. Mattel, and S. Declich. 2001. The increasing burden of infectious diseases on hospital services at St Mary's Hospital Lacor, Gulu, Uganda. Am. J. Trop. Med. Hyg. 64:154-158.
2. Anonymous. 1990. Update Filovirus infections among persons with occupational exposure to nonhuman primates. Morb. Mortal. Wkly. Rep. 39:273.
3. Baize, S., E. M. Leroy, M. C. Georges-Courbot, M. Capron, J. Lansoud-Soukate, P. Debre, S. P. Fisher-Hoch, J. B. McCormick, and A. J. Georges. 1999. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5:423-426.
4. Basler, C. F., X. Wang, E. Muhlberger, V. Volchkov, J. Paragas, H. D. Klenk, A. Garcia-Sastre, and P. Palese. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA 97:12289-12294.
5. + T-cell-deficient mice. J. Virol. 68:4700-4704.
6. Bell, S. J., D. A. Cooper, B. E. Kemp, R. R. Doherty, and R. Penny. 1992. Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI). Clin. Exp. Immunol. 90:6-12.
7. Boere, W. A., B. J. Benalssa-Trouw, T. Harmsen, T. Erich, C. A. Kraaljeveld, and H. Snippe. 1985. Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus. J. Virol. 54:546-551.
8. Bray, M. 2001. The role of the Type I interferon response in the resistance of mice to filovirus infection. J. Gen. Virol. 82:1365-1373.
9. Bray, M., K. Davis, T. Geisbert, C. Schmaljohn, and J. Huggins. 1998. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 178:651-661.
10. Busico, K. M., K. L. Marshall, T. G. Ksiazek, T. H. Roels, Y. Fleerackers, H. Feldmann, A. S. Khan, and C. J. Peters. 1999. Prevalence of immunoglobulin G antibodies to Ebola virus in individuals during an Ebola virus outbreak, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179(Suppl. 1):S102-S107.
11. Bwaka, M. A., M. J. Bonnet, P. Calain, R. Colebunders, A. De Roo, Y. Gulmard, K. R. Katwiki, K. Kibadi, M. A. Kipasa, K. J. Kuvula, B. B. Mapanda, M. Massamba, K. D. Mupapa, J. J. Muyembe-Tamfum, E. Ndaberey, C. J. Peters, P. E. Rollin, and E. Van den Enden. 1999. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J. Infect. Dis. 179(Suppl. 1):S1-S7.
12. Byrnes, A. P., J. E. Durbin, and D. E. Griffin. 2000. Control of Sindbis virus infection by antibody in interferon-deficient mice. J. Virol. 74:3905-3908.
13. Doherty, P. C., D. J. Topham, R. A. Tripp, R. D. Cardin, J. W. Brooks, and P. G. Stevenson. 1997. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:105-117.
14. Emond, R. T., B. Evans, E. T. Bowen, and G. Lloyd. 1977. A case of Ebola virus infection. Br. Med. J. 2:541-544.
15. Fabiani, M., C. Ble, P. Grivel, M. Lukwiya, and S. Declich. 1998. 1989-1996 HIV-1 prevalence trends among different risk groups in Gulu District, North Uganda. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:514.
16. Formenty, P., C. Boesch, M. Wyers, C. Steiner, F. Donati, F. Dind, F. Walker, and B. Le Guenno. 1999. Ebola virus outbreak among wild chimpanzees living in a rain forest of Cote d'Ivoire. J. Infect. Dis. 179(Suppl. 1):S120-S126.
17. Georges, A. J., E. M. Leroy, A. A. Renaut, C. T. Benissan, R. J. Nabias, M. T. Ngoc, P. I. Obiang, J. P. Lepage, E. J. Bertherat, D. D. Benoni, E. J. Wickings, J. P. Amblard, J. M. Lansoud-Soukate, J. M. Milleliri, S. Baize, and M. C. Georges-Courbot. 1999. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J. Infect. Dis. 179(Suppl. 1):S65-S75.
18. Gupta, M., S. Mahanty, R. Ahmed, and P. E. Rollin. 2001. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology 284:20-25.
19. Gupta, M., S. Mahanty, M. Bray, R. Ahmed, and P. E. Rollin. 2001. Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J. Virol. 75:4649-4654.
20. Harcourt, B. H., A. Sanchez, and M. K. Offermann. 1998. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells. Virology 252:179-188.
21. Hensley, L. E., H. A. Young, P. B. Jahrling, and T. W. Geisbert. 2002. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol. Lett. 80:169-179.
22. Jamieson, B. D., and R. Ahmed. 1989. T-cell memory. Long-term persistence of virus-specific cytotoxic T cells. J. Exp. Med. 169:1993-2005.
23. Ksiazek, T. G., P. E. Rollin, P. B. Jahrling, E. Johnson, D. W. Dalgard, and C. J. Peters. 1992. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J. Clin. Microbiol. 30:947-950.
24. Ksiazek, T. G., P. E. Rollin, A. J. Williams, D. S. Bressler, M. L. Martin, R. Swanepoel, F. J. Burt, P. A. Leman, A. S. Khan, A. K. Rowe, R. Mukunu, A. Sanchez, and C. J. Peters. 1999. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and immunoglobulin G and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179(Suppl. 1):S177-S187.
25. Leroy, E. M., S. Baize, E. Mavoungou, and C. Apetrei. 2002. Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. J. Gen. Virol. 83:67-73.
26. Leroy, E. M., S. Souquiere, P. Rouquet, and D. Drevet. 2002. Reemergence of ebola haemorrhagic fever in Gabon. Lancet 359:712.
27. Locksley, R. M., and C. B. Wilson. 1995. Cell-mediated immunity and its role in host defense, p. 137-138. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed., vol. 1. Churchill Livingstone, New York, N.Y.
28. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
29. Okware, S. I., F. G. Omaswa, S. Zaramba, A. Opio, J. J. Lutwama, J. Kamugisha, E. B. Rwaguma, P. Kagwa, and M. Lamunu. 2002. An outbreak of Ebola virus in Uganda. Trop. Med. Int. Health 7:1068-1075.
30. Peters, C. J., and J. W. LeDuc. 1999. An introduction to Ebola virus: the virus and the disease. J. Infect. Dis. 179(Suppl. 1):ix-xvi.
31. Promedmail. 2003. Ebola virus outbreak in Congo.
32. Rao, M., G. R. Matyas, F. Grieder, K. Anderson, P. B. Jahrling, and C. R. Alving. 1999. Cytotoxic T lymphocytes to Ebola virus Zaire virus are induced in mice by immunization with liposomes containing lipid A. Vaccine 17: 2991-2998.
33. -/- mice. J. Virol. 74:9762-9765.
34. Rodriguez, L. L., A. De Roo, Y. Guimard, S. G. Trappier, A. Sanchez, D. Bressler, A. J. Williams, A. K. Rowe, J. Bertolli, A. S. Khan, T. G. Ksiazek, C. J. Peters, and S. T. Nichol. 1999. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179(Suppl. 1):S170-S176.
35. Thomsen, A. R., A. Nansen, C. Andersen, J. Johansen, O. Marker, and J. P. Christensen. 1997. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus. Int. Immunol. 9:1757-1766.
36. Vanderzanden, L., M. Bray, D. Fuller, T. Roberts, D. Custer, K. Spik, P. Jahrling, J. Huggins, A. Schmaljohn, and C. Schmaljohn. 1998. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology 246:134-144.
37. Villinger, F., P. E. Rollin, S. S. Brar, N. F. Chikkala, J. Winter, J. B. Sundstrom, S. R. Zaki, R. Swanepoel, A. A. Ansari, and C. J. Peters. 1999. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 179(Suppl. 1):S188-S191.
38. World Health Organization. 2002. Ebola virus haemorrhagic fever in Gabon/ The Republic of the Congo-update 22. WHO Disease Outbreak Report. World Health Organization, Geneva, Switzerland.
39. Wilson, J. A., and M. K. Hart. 2001. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein. J. Virol. 75:2660-2664.
40. Wilson, J. A., M. Hevey, R. Bakken, S. Guest, M. Bray, A. L. Schmaljohn, and M. K. Hart. 2000. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287:1664-1666.
41. Yang, Z. Y., H. J. Duckers, N. J. Sullivan, A. Sanchez, E. G. Nabel, and G. J. Nabel. 2000. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6:886-889.
42. Zaki, S. R., W. J. Shieh, P. W. Greer, C. S. Goldsmith, T. Ferebee, J. Katshitshi, F. K. Tshioko, M. A. Bwaka, R. Swanepoel, P. Calain, A. S. Khan, E. Lloyd, P. E. Rollin, T. G. Ksiazek, and C. J. Peters. 1999. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J. Infect. Dis. 179(Suppl. 1):S36-S47.